Biotechnology
Medical
Biopharmaceutical

Mirati Therapeutics

$76.74
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$2.25 (3.02%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell MRTX and other stocks, options, ETFs, and crypto commission-free!

About

Mirati Therapeutics, Inc. Common Stock, also called Mirati Therapeutics, is a clinical-stage oncology company, which engages in developing a pipeline of oncology products to treat genetic, immunological and epigenetic drivers of cancer in subsets of cancer patients. Read More Its clinical pipeline consists of glesatinib, sitravatinib and mocetinostat. The company was founded on December 13, 1995 and is headquartered in San Diego, CA.

Employees
63
Headquarters
San Diego, California
Founded
1995
Market Cap
2.76B
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
628.40K
High Today
$77.33
Low Today
$75.10
Open Price
$75.10
Volume
176.43K
52 Week High
$80.00
52 Week Low
$28.50

Collections

Biotechnology
Medical
Biopharmaceutical
Pharmaceutical
Cancer Prevention
Health
Therapy
Technology

News

Seeking AlphaMay 14

Mirati fortunes with KRAS inhibitor tied to Amgen's - JPMorgan

JPMorgan analyst Anupam Rama says Mirati Therapeutics (MRTX +1% ) may experience volatility related to Amgen's (AMGN +0.5% ) fortunes with pipeline candidate AMG 510, in early-stage development for certain types of cancer.

203
NasdaqMay 7

Noteworthy Tuesday Option Activity: CCK, BAC, MRTX

50
Yahoo FinanceMay 7

What You Must Know About Mirati Therapeutics, Inc.'s (NASDAQ:MRTX) Beta Value

Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! If you own shares in Mirati Therapeutics, Inc. (NASDAQ:MRTX) then it's worth thinking about how it contributes to the volatility of your portfolio, overall. In finance, Beta is a measure of volatility. Modern finance theory considers volatility to be a measure of risk, and there are two main types of price volatility. The first category is company specific volatility. This can be deal...

29

Earnings

-$1.17
-$0.95
-$0.73
-$0.51
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 1, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.